Navigation Links
Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
Date:10/18/2007

our ability to control or predict. See "Risk Factors" under "Item 6. Management's Discussion and Analysis of Financial Condition and Results of Operation" from our Annual Report on Form 10-KSB for the year ended December 31, 2006, and other descriptions in the Company's public filings with the Securities and Exchange Commission for a discussion of such risks, including the Company's need for additional funds, the Company's dependence on a limited number of therapeutic compounds, the stage of the products the Company is developing, uncertainties relating to clinical trials and regulatory reviews, competition and dependence on collaborative partners, the Company's ability to avoid infringement of the patent rights of others, and the Company's ability to obtain adequate patent protection and to enforce these rights. Because of these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements. Furthermore, forward-looking statements speak only as of the date they are made. Avicena does not undertake any obligation to update or review any such forward-looking information, whether as a result of new information, future events or otherwise.

Contact:

The Ruth Group (on behalf of Avicena Group)

Sara Ephraim (investors)

(646) 536-7002

sephraim@theruthgroup.com

Janine McCargo / Jason Rando (media)

(646) 536-7033 / 7025

jmccargo@theruthgroup.com or jrando@theruthgroup.com


'/>"/>
SOURCE Avicena Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
5. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
6. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
9. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
10. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
11. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... SHENZHEN, China , May 22, 2015  China ... the "Company"), a leading retail drugstore chain in ... directly operated stores, today announced the resignation of Mr. ... Officer for personal reasons, effective immediately. Ms. Rebecca ... Officer by the Company,s board of directors, effective immediately. ...
(Date:5/21/2015)... , May 21, 2015  When Ryan ... the side of his neck, he figured ... a couple weeks off from weight lifting. ... away.                               A series ... was referred to Michel Kliot, MD ...
(Date:5/21/2015)... Research and Markets ( ... "Market Assessment of Respiratory Diagnostics in the ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service ... market in the United States ... service provides detailed analysis of the current and ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4United States and Europe Respiratory Diagnostics Market Assessment 2015 2
(Date:5/22/2015)... 2015 A Phase 3 French ... Society of Clinical Oncology (ASCO)’s annual meeting at ... for those patients who received bevacizumab in addition ... Bevacizumab (Avastin® Genentech, Inc.) is an antibody that ... already routinely used to treat many other cancers, ...
(Date:5/22/2015)... In an effort to support the ... offering to donate $5 dollars for every maintenance call, ... water softening system. Customers have their needs serviced, and ... business; and the Special Olympics receives money. Hence the ... over 4.4 million athletes, and boasts a myriad of ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 A new ... featuring experts in the field of Physical Therapy. ... that takes the mystery out of physical therapy and ... range of motion for a variety of ailments and ... establish a personalized exercise plan that enhances daily activities ...
(Date:5/22/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... religious leaders to make changes in order to achieve peace ... discusses the history of war, how it started, why it ... mankind was created to lead peaceful, joyful lives, very much ... “Yahweh created mankind, according to His Plan, which is still ...
(Date:5/21/2015)... 21, 2015 World Patent Marketing, a ... the Troll Motor Guide, a boat patent that aims ... "The recreational boating industry has reached an annual revenue ... Creative Director of World Patent Marketing , "Americans ... predicts continued steady growth of seven percent in new ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2Health News:Yisrayl Hawkins Calls on All Religions to Wake Up and Make Drastic Changes to End Suffering in New Letter 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3
... ... Mark Merritt released the following statement on today’s Federal Workforce, Postal Service, and ... the Federal Employees Health Benefits Program (FEHBP) , ... Washington, DC (Vocus) February 23, 2010 ...
... exposure time , TUESDAY, Feb. 23 (HealthDay News) -- ... as much as 91 percent less radiation than standard ... generated great enthusiasm in recent years, due to its ... coronary artery disease. However, that enthusiasm has been tempered ...
... improve life expectancy, study finds , TUESDAY, Feb. ... and MRI appears to be a cost-effective way to ... breast cancer, U.S. researchers say. , In the new ... Hospital in Boston, and colleagues used statistical modeling to ...
... likely to develop dementia than non-hospitalized, study finds , ... been hospitalized have an increased risk of cognitive decline. , ... 1994 through 2007 on 2,929 people, aged 65 and older, ... study. During an average follow-up of 6.1 years, 1,287 were ...
... shortages, researchers say, , TUESDAY, Feb. 23 (HealthDay News) -- Although ... sharp decline in the average number of hours they work each ... the average work week of doctors remained steady, but between 1996 ... dropped nearly four hours a week -- from 54.9 to 51 ...
... ... ... ... ...
Cached Medicine News:Health News:PCMA: Proposed Overhaul of FEHBP Pharmacy Benefit,Would Undermine Cost-Saving Tools, ,Reduce Choices for 8 Million Americans, 2Health News:PCMA: Proposed Overhaul of FEHBP Pharmacy Benefit,Would Undermine Cost-Saving Tools, ,Reduce Choices for 8 Million Americans, 3Health News:PCMA: Proposed Overhaul of FEHBP Pharmacy Benefit,Would Undermine Cost-Saving Tools, ,Reduce Choices for 8 Million Americans, 4Health News:New Heart CT Scans Deliver Far Less Radiation: Study 2Health News:Mammogram Plus MRI Seems Cost-Effective in High-Risk Women 2Health News:Hospital Stays May Spur Brain Decline in Seniors 2Health News:Doctors Working Less, Earning Less 2Health News:Doctors Working Less, Earning Less 3Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 2Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 3Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 4
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Speculum with malleable plate to support flap during ablation of thestromal bed....
Adjustable wire speculum with 17 mm open blades. Lid tension adjustable throughout procedure with thumb screw control. Angled 45 degrees....
Open 13 mm blades. Screw-controlled locking mechanism. Dull finish....
Medicine Products: